TrialCancer science2018

Cost-effectiveness of aprepitant in Japanese patients treated with cisplatin-containing highly emetogenic chemotherapy.

Ikuto Tsukiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.